Amicus Therapeutics to Announce Full-Year 2024 Financial Results on February 19, 2025
Amicus Therapeutics (FOLD) has scheduled a conference call and live audio webcast for February 19, 2025, at 8:30 a.m. ET to discuss their full-year 2024 financial results. Participants must pre-register online to receive dial-in details and a personal PIN for phone access. A webcast will be available through the Investors section of Amicus' website, with participants advised to register 15 minutes before the call starts.
The presentation materials and archived webcast will be accessible on the company's website after the event. Amicus Therapeutics is a global biotechnology company focused on developing and delivering medicines for rare diseases.
Amicus Therapeutics (FOLD) ha programmato una conferenza telefonica e una webcast audio dal vivo per il 19 febbraio 2025, alle 8:30 ora ET per discutere i risultati finanziari dell'intero anno 2024. I partecipanti devono preregistrarsi online per ricevere i dettagli di accesso telefonico e un PIN personale. Sarà disponibile una webcast nella sezione Investitori del sito web di Amicus, con i partecipanti che sono invitati a registrarsi 15 minuti prima dell'inizio della chiamata.
Il materiale della presentazione e la webcast archiviata saranno accessibili sul sito web dell'azienda dopo l'evento. Amicus Therapeutics è un'azienda biotecnologica globale focalizzata sullo sviluppo e la fornitura di medicinali per malattie rare.
Amicus Therapeutics (FOLD) ha programado una llamada de conferencia y un webcast de audio en vivo para el 19 de febrero de 2025, a las 8:30 a.m. ET para discutir sus resultados financieros del año completo 2024. Los participantes deben registrarse previamente en línea para recibir los detalles de acceso por teléfono y un PIN personal. Se dispondrá de un webcast a través de la sección de Inversores del sitio web de Amicus, y se aconseja a los participantes que se registren 15 minutos antes de que comience la llamada.
Los materiales de la presentación y el webcast archivado estarán disponibles en el sitio web de la empresa después del evento. Amicus Therapeutics es una empresa de biotecnología global centrada en el desarrollo y entrega de medicamentos para enfermedades raras.
아미쿠스 치료제 (FOLD)는 2025년 2월 19일 오전 8시 30분 ET에 2024년 전체 재무 결과를 논의하기 위한 전화 회의 및 실시간 오디오 웹캐스트를 예정하였습니다. 참여자는 전화 접속을 위한 다이얼인 세부정보와 개인 PIN을 받기 위해 온라인으로 사전 등록해야 합니다. 웹캐스트는 아미쿠스 웹사이트의 투자자 섹션을 통해 제공되며, 참여자는 전화 회의 시작 15분 전에 등록하는 것이 좋습니다.
프레젠테이션 자료와 저장된 웹캐스트는 이벤트 후 회사 웹사이트에서 접근할 수 있습니다. 아미쿠스 치료제는 희귀 질환을 위한 의약품 개발 및 제공에 집중하는 글로벌 생명공학 회사입니다.
Amicus Therapeutics (FOLD) a programmé une conférence téléphonique et un webinaire audio en direct pour le 19 février 2025 à 8h30 ET afin de discuter des résultats financiers de l'année complète 2024. Les participants doivent s'inscrire à l'avance en ligne pour recevoir les détails de connexion téléphonique et un code PIN personnel. Un webinaire sera disponible dans la section Investisseurs du site web d'Amicus, et il est conseillé aux participants de s'inscrire 15 minutes avant le début de l'appel.
Le matériel de présentation et le webinaire archivé seront accessibles sur le site web de l'entreprise après l'événement. Amicus Therapeutics est une entreprise biopharmaceutique mondiale axée sur le développement et la fourniture de médicaments pour les maladies rares.
Amicus Therapeutics (FOLD) hat eine Telefonkonferenz und einen Live-Audio-Webcast für den 19. Februar 2025 um 8:30 Uhr ET angesetzt, um die Finanzzahlen für das Gesamtjahr 2024 zu besprechen. Teilnehmer müssen sich online vorab registrieren, um Dial-In-Details und eine persönliche PIN für den Telefonzugang zu erhalten. Ein Webcast ist im Bereich Investoren der Amicus-Website verfügbar, wobei den Teilnehmern geraten wird, sich 15 Minuten vor Beginn des Anrufs zu registrieren.
Die Präsentationsmaterialien und der archivierte Webcast werden nach der Veranstaltung auf der Unternehmenswebsite zugänglich sein. Amicus Therapeutics ist ein globales Biotechnologieunternehmen, das sich auf die Entwicklung und Bereitstellung von Arzneimitteln für seltene Krankheiten konzentriert.
- None.
- None.
PRINCETON, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Wednesday, February 19, 2025, at 8:30 a.m. ET to discuss financial results for the full-year ended December 31, 2024.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When will Amicus Therapeutics (FOLD) release its full-year 2024 financial results?
How can investors access FOLD's full-year 2024 earnings call?
Will FOLD's earnings presentation materials be available after the call?
What time should investors register for FOLD's earnings webcast?
